APO RESEARCH · REPORT
Mupirocin Ointment
Mupirocin is an antibiotic that prevents bacteria from growing on skin. Mupirocin Ointment (for use on the skin) is used to treat skin infections such as impetigo (IM-pe-TYE-go) or a "Staph" infection of the skin.
Product & engineering
Understand the product.
Mupirocin is an antibiotic that prevents bacteria from growing on skin. Mupirocin Ointment (for use on the skin) is used to treat skin infections such as impetigo (IM-pe-TYE-go) or a "Staph" infection of the skin.
Selected research
Industry Growth & Trends
Global Mupirocin Ointment Industry Growth and Trends Forecast to 2032
Market perspective
Mupirocin is an antibiotic that prevents bacteria from growing on skin. Mupirocin Ointment (for use on the skin) is used to treat skin infections such as impetigo (IM-pe-TYE-go) or a "Staph" infection of the skin.
Currently, global production of Mupirocin Ointment is concentrated as there are few manufacturers engaged in the industry. The largest manufacturer is Glenmark Pharms, who owns 37% revenue market share.
As for the region, North America is the largest consumption region, holding 35% revenue market share, followed by China, with 22% market share.
Read the full market overview
Mupirocin Ointment is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria. Among various applications, demand from Retail Pharmacy is the largest one.
Above 20g Mupirocin Ointment accounted for a major share of 30% the global Mupirocin Ointment market.
Report Scope
This report provides a structured, data-driven view of the global Mupirocin Ointment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Mupirocin Ointment market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mupirocin Ointment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mupirocin Ointment.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Mupirocin Ointment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Mupirocin Ointment Market by Company
Glenmark Pharms
Glaxosmithkline
SmithKline & French
Humanwell Healthcare
Taro Pharmaceutical
Teva
Perrigo
Hanzhou Zhuyangxin Pharmaceutical
Mupirocin Ointment Segment by Type
Below 10g
10g-20g
Above 20g
Mupirocin Ointment Segment by Sales Channel
Hospital
Retail Pharmacy
Others
Mupirocin Ointment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mupirocin Ointment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mupirocin Ointment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mupirocin Ointment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mupirocin Ointment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Mupirocin Ointment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Below 10g
- 10g-20g
- Above 20g
Applications
- Hospital
- Retail Pharmacy
- Others
Companies covered
- Glenmark Pharms
- Glaxosmithkline
- SmithKline & French
- Humanwell Healthcare
- Taro Pharmaceutical
- Teva
- Perrigo
- Hanzhou Zhuyangxin Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Mupirocin Ointment Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Mupirocin Ointment Sales Estimates and Forecasts (2021-2032)
- 1.3 Mupirocin Ointment Market by Type
- 1.3.1 Below 10g
- 1.3.2 10g-20g
- 1.3.3 Above 20g
- 1.4 Global Mupirocin Ointment Market Size by Type
- 1.4.1 Global Mupirocin Ointment Market Size Overview by Type (2021-2032)
- 1.4.2 Global Mupirocin Ointment Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Mupirocin Ointment Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Mupirocin Ointment Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Mupirocin Ointment Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Mupirocin Ointment Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Mupirocin Ointment Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Mupirocin Ointment Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Mupirocin Ointment Industry Trends
- 2.2 Mupirocin Ointment Industry Drivers
- 2.3 Mupirocin Ointment Industry Opportunities and Challenges
- 2.4 Mupirocin Ointment Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Mupirocin Ointment Revenue (2021-2026)
- 3.2 Global Top Players by Mupirocin Ointment Sales (2021-2026)
- 3.3 Global Top Players by Mupirocin Ointment Price (2021-2026)
- 3.4 Global Mupirocin Ointment Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Mupirocin Ointment Major Company Production Sites & Headquarters
- 3.6 Global Mupirocin Ointment Company, Product Type & Application
- 3.7 Global Mupirocin Ointment Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Mupirocin Ointment Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Mupirocin Ointment Players Market Share by Revenue in 2025
- 3.8.3 2025 Mupirocin Ointment Tier 1, Tier 2, and Tier 3
4 Mupirocin Ointment Regional Status and Outlook
- 4.1 Global Mupirocin Ointment Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Mupirocin Ointment Historic Market Size by Region
- 4.2.1 Global Mupirocin Ointment Sales in Volume by Region (2021-2026)
- 4.2.2 Global Mupirocin Ointment Sales in Value by Region (2021-2026)
- 4.2.3 Global Mupirocin Ointment Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Mupirocin Ointment Forecasted Market Size by Region
- 4.3.1 Global Mupirocin Ointment Sales in Volume by Region (2027-2032)
- 4.3.2 Global Mupirocin Ointment Sales in Value by Region (2027-2032)
- 4.3.3 Global Mupirocin Ointment Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mupirocin Ointment by Application
- 5.1 Mupirocin Ointment Market by Sales Channel
- 5.1.1 Hospital
- 5.1.2 Retail Pharmacy
- 5.1.3 Others
- 5.2 Global Mupirocin Ointment Market Size by Sales Channel
- 5.2.1 Global Mupirocin Ointment Market Size Overview by Application (2021-2032)
- 5.2.2 Global Mupirocin Ointment Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Mupirocin Ointment Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Sales Channel
- 5.3.1 North America Mupirocin Ointment Sales Breakdown by Sales Channel (2021-2026)
- 5.3.2 Europe Mupirocin Ointment Sales Breakdown by Sales Channel (2021-2026)
- 5.3.3 Asia-Pacific Mupirocin Ointment Sales Breakdown by Sales Channel (2021-2026)
- 5.3.4 South America Mupirocin Ointment Sales Breakdown by Sales Channel (2021-2026)
- 5.3.5 Middle East and Africa Mupirocin Ointment Sales Breakdown by Sales Channel (2021-2026)
6 Company Profiles
- 6.1 Glenmark Pharms
- 6.1.1 Glenmark Pharms Company Information
- 6.1.2 Glenmark Pharms Business Overview
- 6.1.3 Glenmark Pharms Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Glenmark Pharms Mupirocin Ointment Product Portfolio
- 6.1.5 Glenmark Pharms Recent Developments
- 6.2 Glaxosmithkline
- 6.2.1 Glaxosmithkline Company Information
- 6.2.2 Glaxosmithkline Business Overview
- 6.2.3 Glaxosmithkline Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Glaxosmithkline Mupirocin Ointment Product Portfolio
- 6.2.5 Glaxosmithkline Recent Developments
- 6.3 SmithKline & French
- 6.3.1 SmithKline & French Company Information
- 6.3.2 SmithKline & French Business Overview
- 6.3.3 SmithKline & French Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 SmithKline & French Mupirocin Ointment Product Portfolio
- 6.3.5 SmithKline & French Recent Developments
- 6.4 Humanwell Healthcare
- 6.4.1 Humanwell Healthcare Company Information
- 6.4.2 Humanwell Healthcare Business Overview
- 6.4.3 Humanwell Healthcare Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Humanwell Healthcare Mupirocin Ointment Product Portfolio
- 6.4.5 Humanwell Healthcare Recent Developments
- 6.5 Taro Pharmaceutical
- 6.5.1 Taro Pharmaceutical Company Information
- 6.5.2 Taro Pharmaceutical Business Overview
- 6.5.3 Taro Pharmaceutical Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Taro Pharmaceutical Mupirocin Ointment Product Portfolio
- 6.5.5 Taro Pharmaceutical Recent Developments
- 6.6 Teva
- 6.6.1 Teva Company Information
- 6.6.2 Teva Business Overview
- 6.6.3 Teva Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Teva Mupirocin Ointment Product Portfolio
- 6.6.5 Teva Recent Developments
- 6.7 Perrigo
- 6.7.1 Perrigo Company Information
- 6.7.2 Perrigo Business Overview
- 6.7.3 Perrigo Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Perrigo Mupirocin Ointment Product Portfolio
- 6.7.5 Perrigo Recent Developments
- 6.8 Hanzhou Zhuyangxin Pharmaceutical
- 6.8.1 Hanzhou Zhuyangxin Pharmaceutical Company Information
- 6.8.2 Hanzhou Zhuyangxin Pharmaceutical Business Overview
- 6.8.3 Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Product Portfolio
- 6.8.5 Hanzhou Zhuyangxin Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America Mupirocin Ointment Sales by Country
- 7.1.1 North America Mupirocin Ointment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Mupirocin Ointment Sales by Country (2021-2026)
- 7.1.3 North America Mupirocin Ointment Sales Forecast by Country (2027-2032)
- 7.2 North America Mupirocin Ointment Market Size by Country
- 7.2.1 North America Mupirocin Ointment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Mupirocin Ointment Market Size by Country (2021-2026)
- 7.2.3 North America Mupirocin Ointment Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Mupirocin Ointment Sales by Country
- 8.1.1 Europe Mupirocin Ointment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Mupirocin Ointment Sales by Country (2021-2026)
- 8.1.3 Europe Mupirocin Ointment Sales Forecast by Country (2027-2032)
- 8.2 Europe Mupirocin Ointment Market Size by Country
- 8.2.1 Europe Mupirocin Ointment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Mupirocin Ointment Market Size by Country (2021-2026)
- 8.2.3 Europe Mupirocin Ointment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Mupirocin Ointment Sales by Country
- 9.1.1 Asia-Pacific Mupirocin Ointment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Mupirocin Ointment Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Mupirocin Ointment Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Mupirocin Ointment Market Size by Country
- 9.2.1 Asia-Pacific Mupirocin Ointment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Mupirocin Ointment Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Mupirocin Ointment Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Mupirocin Ointment Sales by Country
- 10.1.1 South America Mupirocin Ointment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Mupirocin Ointment Sales by Country (2021-2026)
- 10.1.3 South America Mupirocin Ointment Sales Forecast by Country (2027-2032)
- 10.2 South America Mupirocin Ointment Market Size by Country
- 10.2.1 South America Mupirocin Ointment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Mupirocin Ointment Market Size by Country (2021-2026)
- 10.2.3 South America Mupirocin Ointment Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Mupirocin Ointment Sales by Country
- 11.1.1 Middle East and Africa Mupirocin Ointment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Mupirocin Ointment Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Mupirocin Ointment Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Mupirocin Ointment Market Size by Country
- 11.2.1 Middle East and Africa Mupirocin Ointment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Mupirocin Ointment Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Mupirocin Ointment Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Mupirocin Ointment Value Chain Analysis
- 12.1.1 Mupirocin Ointment Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Mupirocin Ointment Production Mode & Process
- 12.2 Mupirocin Ointment Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Mupirocin Ointment Distributors
- 12.2.3 Mupirocin Ointment Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst